Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 1642914Erstellt: 26. Oktober 2026

N'-Hydroxy-4-methylbenzenecarboximidamide → 4-({3-[3-(4-Methylphenyl)-1,2,4-oxadiazol-5-yl]-5-[4-(trifluoromethoxy)phenyl]piperidin-1-yl}-carbonyl)morpholine

https://huagongshe.com/reaction/1642914

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
EduktN'-Hydroxy-4-methylbenzenecarboximidamideHCID 209113—
Edukt1-(Morpholin-4-ylcarbonyl)-5-[4-(trifluoromethoxy)phenyl]piperidine-3-carboxylic acidHCID 58002500—
Produkt4-({3-[3-(4-Methylphenyl)-1,2,4-oxadiazol-5-yl]-5-[4-(trifluoromethoxy)phenyl]piperidin-1-yl}-carbonyl)morpholineHCID 58002735—

Reaktionsschritte

80 mg (0.20 mmol) of 1-(morpholin-4-ylcarbonyl)-5-[4-(trifluoromethoxy)phenyl]piperidine-3-carboxylic acid (Example 44A) and 33 mg (0.22 mmol, 1.1 eq.) of N′-hydroxy-4-methylbenzenecarboximidamide were reacted according to the General Method 1. Yield: 68 mg (66% of theory)

Herkunft & Nachweise

DOI10.6084/m9.figshare.5104873.v1
PatentnummerUS08119663B2
Quelldatensatzuspto-grants-2012_02
ORD IDord-fa7e6c3e660942b58df47f675298473e
Quellennotizuspto-grants-2012_02